Robitussin



Indications and Reactions:

Role Indications Reactions
Primary
Nasopharyngitis 17.8%
Drug Use For Unknown Indication 15.6%
Cough 13.3%
Lower Respiratory Tract Infection 8.9%
Headache 6.7%
Influenza Like Illness 6.7%
Bipolar Disorder 4.4%
Influenza 4.4%
Pyrexia 4.4%
Convulsion 2.2%
Gastric Disorder 2.2%
Hypersensitivity 2.2%
Nasal Congestion 2.2%
Product Used For Unknown Indication 2.2%
Psoriatic Arthropathy 2.2%
Rhinorrhoea 2.2%
Upper Respiratory Tract Congestion 2.2%
Pneumonia 13.3%
Vomiting 10.0%
Chromaturia 6.7%
Drug Hypersensitivity 6.7%
Hypertension 6.7%
Off Label Use 6.7%
Swelling Face 6.7%
Abdominal Pain Upper 3.3%
Cardiac Arrest 3.3%
Cardiac Disorder 3.3%
Chronic Obstructive Pulmonary Disease 3.3%
Constipation 3.3%
Convulsion 3.3%
Fall 3.3%
Hallucination 3.3%
Insomnia 3.3%
Loss Of Consciousness 3.3%
Mania 3.3%
Opiates Positive 3.3%
Rash Generalised 3.3%
Secondary
Headache 14.0%
Nasopharyngitis 12.4%
Product Used For Unknown Indication 10.1%
Drug Use For Unknown Indication 8.5%
Pyrexia 7.8%
Nausea 6.2%
Cough 5.4%
Gastrooesophageal Reflux Disease 4.7%
Respiratory Tract Congestion 3.9%
Acid Reflux (Esophageal) 3.1%
Bronchitis 3.1%
Cold 3.1%
Haemoglobin Decreased 3.1%
Premature Labour 3.1%
Candidiasis 2.3%
Polycystic Ovaries 2.3%
Vomiting 2.3%
Chronic Obstructive Pulmonary Disease 1.6%
Drug Dependence 1.6%
Prophylaxis 1.6%
Hypersensitivity 14.8%
Drug Exposure During Pregnancy 7.4%
Hallucination 7.4%
Somnolence 7.4%
Yellow Skin 7.4%
Dizziness 3.7%
Drug Abuser 3.7%
Drug Hypersensitivity 3.7%
Hepatocellular Damage 3.7%
Ill-defined Disorder 3.7%
Intentional Drug Misuse 3.7%
Maternal Exposure During Pregnancy 3.7%
Myocardial Infarction 3.7%
Nausea 3.7%
Palpitations 3.7%
Pneumonia 3.7%
Premature Baby 3.7%
Premature Labour 3.7%
Throat Irritation 3.7%
Toxic Epidermal Necrolysis 3.7%
Concomitant
Product Used For Unknown Indication 20.9%
Drug Use For Unknown Indication 9.5%
Pain 7.1%
Cough 7.0%
Depression 7.0%
Upper Respiratory Tract Infection 5.0%
Bronchitis 4.9%
Hypertension 4.8%
Non-small Cell Lung Cancer 4.1%
Anxiety 3.7%
Nausea 3.7%
Pyelonephritis 3.5%
Constipation 3.1%
Restless Legs Syndrome 2.7%
Acute Lymphocytic Leukaemia 2.4%
Back Pain 2.3%
Chronic Obstructive Pulmonary Disease 2.2%
Sinusitis 2.1%
Type 2 Diabetes Mellitus 2.1%
Prophylaxis 2.0%
Vomiting 21.1%
Weight Increased 6.2%
Wound Infection 6.2%
Type 2 Diabetes Mellitus 5.6%
Pyrexia 5.0%
Urinary Tract Infection 5.0%
White Blood Cell Count Increased 5.0%
Pneumonia Aspiration 4.3%
Therapeutic Agent Toxicity 4.3%
Weight Decreased 4.3%
Pneumonia 3.7%
Sepsis 3.7%
Transposition Of The Great Vessels 3.7%
Upper Respiratory Tract Infection 3.7%
Uveitis 3.7%
Pulmonary Valve Stenosis 3.1%
Vision Blurred 3.1%
Wheezing 3.1%
Nausea 2.5%
Pleural Effusion 2.5%
Interacting
Product Used For Unknown Indication 15.6%
Respiratory Tract Congestion 15.6%
Depression 13.3%
Insomnia 13.3%
Abdominal Discomfort 11.1%
Hypertension 11.1%
Bipolar Disorder 4.4%
Gastric Disorder 4.4%
Arrhythmia 2.2%
Coagulopathy 2.2%
Convulsion 2.2%
Nasal Congestion 2.2%
Nasopharyngitis 2.2%
Fatigue 28.6%
Moaning 28.6%
Feeling Abnormal 14.3%
Mania 14.3%
Somnolence 14.3%